Michelle Spaan

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Letter: Association of Diabetes Mellitus With Post-TIPS Hepatic Encephalopathy in a Predominantly Viral Cirrhosis Cohort-Authors' Reply.

Letter: Association of Diabetes Mellitus With Post-TIPS Hepatic Encephalopathy in a Predominantly Viral Cirrhosis Cohort-Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: January 29, 2026

Editorial: TIPS in the Era of Aging and Metabolic Comorbidity-Rethinking Risks and Rewards. Authors Reply.

Editorial: TIPS in the Era of Aging and Metabolic Comorbidity-Rethinking Risks and Rewards. Authors Reply.

Journal: Alimentary pharmacology & therapeutics

Published: December 30, 2025

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt.

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt.

Journal: Alimentary pharmacology & therapeutics

Published: May 23, 2025

Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals.

Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 13, 2024

The effects of nucleoside/nucleotide analogues on host immune cells: the baseline for future immune therapy for HBV?

The effects of nucleoside/nucleotide analogues on host immune cells: the baseline for future immune therapy for HBV?

Journal: Antiviral therapy

Published: April 30, 2020

Interleukin 15 upregulates the expression of PD-1 and TIM-3 on CD4+ and CD8+ T cells.

Interleukin 15 upregulates the expression of PD-1 and TIM-3 on CD4+ and CD8+ T cells.

Journal: American journal of clinical and experimental immunology

Published: April 03, 2020

Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.

Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.

Journal: Journal of hepatology

Published: March 05, 2019

The role of anti-HBs in hepatitis B reactivation during direct-acting antiviral therapy for chronic hepatitis C.

The role of anti-HBs in hepatitis B reactivation during direct-acting antiviral therapy for chronic hepatitis C.

Journal: Antiviral therapy

Published: January 08, 2018

Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy.

Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy.

Journal: PloS one

Published: May 26, 2016

Longitudinal analysis of peripheral and intrahepatic NK cells in chronic HCV patients during antiviral therapy.

Longitudinal analysis of peripheral and intrahepatic NK cells in chronic HCV patients during antiviral therapy.

Journal: Antiviral research

Published: July 21, 2015

Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment.

Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment.

Journal: The Journal of infectious diseases

Published: March 31, 2015

The Intrahepatic T Cell Compartment Does Not Normalize Years After Therapy-Induced Hepatitis C Virus Eradication.

The Intrahepatic T Cell Compartment Does Not Normalize Years After Therapy-Induced Hepatitis C Virus Eradication.

Journal: The Journal of infectious diseases

Published: November 25, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026